drugset / Trial / NCT01069913

Pharmacokinetics Profile Study of BG00012 Standard Formulation and BG00012 Active Pharmaceutical Ingredient

NCT01069913

Phase 1 Completed 14 enrolled Biogen
RandomizedCrossoverOpen-label

Summary

The purpose of this study is to measure two different formulations of BG00012 to determine how much of each formulation of BG00012 reaches the blood stream and how long it takes the body to get rid of it, when given as a single dose.

Timeline

Start
2009-10
Primary completion
2009-10
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator dimethyl fumarate Unknown 240 mg Oral

Indications

No indication recorded.